NCT00397956View on ClinicalTrials.gov

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Sepsis
Interventions
DRUG

MK0826, ertapenem sodium / Duration of Treatment: 14 Days

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00397956 - To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053) | Biotech Hunter | Biotech Hunter